Impact of Delaying DAA Treatment for Chronic Hepatitis C Impact of Delaying DAA Treatment for Chronic Hepatitis C
What is the impact of delaying treatment for different populations of people living with hepatitis C? The authors present a clinical decision tool for informing treatment timing decisions.Liver International (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 18, 2020 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Tennessee infants exposed to hepatitis C at birth often not tested for virus
(Vanderbilt University Medical Center) Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Mauritius: Free Medication for Hepatitis C Patients
[Government of Mauritius] Free medication will be provided by a UK-based biopharmaceutical company, Gilead Sciences, to patients suffering from hepatitis C in Mauritius under a medicine donation programme, announced yesterday, the Prime Minister, Minister of Defence, Home Affairs and External Communications, Minister for Rodrigues, Outer Islands and Territorial Integrity, Mr Pravind Kumar Jugnauth. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 7, 2020 Category: African Health Source Type: news

Cells to Society: Year of the Nurse / Global Impact
This study establishes baseline sociodemographic and clinical characteristics of hospitalized patients in Nepal who were experiencing heart failure.     Read more   Maternal Health ...
Source: Johns Hopkins University and Health Systems Archive - February 6, 2020 Category: Nursing Source Type: news

Baby Boomers Have High Incidence Of Hepatitis C Virus: What Does This Mean, Boomer?
In the 1960 ’s-1980’s, the years before utilization of universal precaution and infection control, transmission of the Hepatitis C virus, via contaminated medical equipment, or contact with contaminated blood products, led to easy transmission of this virus from either person to person or via cont... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 4, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

Hepatitis C no longer an obstacle for transplant recipients
Sharon Price had come to grips with the notion that dialysis would soon be part of his life. Facing a long wait for a new kidney, he was 73 years old and his condition had grown progressively over two years. He was ready to begin the treatment, but first had a request for his doctors at Atrium Health’s Carolinas Medical Center. “I was going to do it [dialysis], no ifs and or buts,” Price says. “But I wanted to put it off for two months because it was summer, and I wanted to do spend time… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

Hepatitis C no longer an obstacle for transplant recipients
Sharon Price had come to grips with the notion that dialysis would soon be part of his life. Facing a long wait for a new kidney, he was 73 years old and his condition had grown progressively over two years. He was ready to begin the treatment, but first had a request for his doctors at Atrium Health’s Carolinas Medical Center. “I was going to do it [dialysis], no ifs and or buts,” Price says. “But I wanted to put it off for two months because it was summer, and I wanted to do spend time… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2020 Category: Biotechnology Authors: Atrium Health Source Type: news

AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
If approved by the European Commission (EC), MAVIRET will be the only pan-genotypic (GT1-6) 8-week treatment option for treatment-naïve, chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis Final European Commission ... Biopharmaceuticals, Regulatory AbbVie, MAVIRET, glecaprevir, pibrentasvir, hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

£ 24m boost for Liverpool led revolutionary long-acting medicine research
(University of Liverpool) The University of Liverpool has been awarded more than £ 24.5 million ($32m) in funding from Unitaid to develop long-acting formulations for malaria and TB prevention, and a single-injection cure for hepatitis C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 31, 2020 Category: Infectious Diseases Source Type: news

Unique new antiviral treatment made using sugar
(University of Manchester) New antiviral materials made from sugar have been developed to destroy viruses on contact and may help in the fight against viral outbreaks. This new development from a collaborative team of international scientists shows promise for the treatment of herpes simplex (cold sore virus), respiratory syncytial virus, hepatitis C, HIV, and Zika virus to name a few. The team have demonstrated success treating a range of viruses in the lab - including respiratory infections to genital herpes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 29, 2020 Category: Infectious Diseases Source Type: news

Treating Opioid Use Disorder, Infectious Diseases in an Integrated Way
The opioid epidemic in the U.S. is driving a simultaneous epidemic of infectious diseases— including HIV, hepatitis C virus (HCV) and bacterial infections, and sexually transmitted infections— but workforce shortages, stigma, and administrative burdens are preventing the integration of opioid use disorder (OUD) and infectious disease services, says a new report from the National Academies of Sciences, Engineering, and Medicine. It recommends a number of state and federal policy actions to address those barriers, including removing insurance requirements on prescribing medications for OUD (i.e., buprenorphine), ...
Source: News from the National Academies - January 23, 2020 Category: Science Source Type: news

Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
The authors describe the principles behind and approach to HCV resistance testing and consider evidence from in vitro studies, clinical trials and real world cohorts on the impact of HCV resistance on treatment outcomes for particular DAA regimens. Five scenarios are identified in the UK and similar settings, where, in the Group's opinion, resistance testing should be performed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 23, 2020 Category: Consumer Health News Source Type: news

Grant targets ‘perfect storm’ threatening lives
Armed with a $1.5 million grant, Yale School of Public Health researcher Gregg Gonsalves is taking on a surge in new cases of HIV and Hepatitis C. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 16, 2020 Category: Universities & Medical Training Source Type: news

Heart Transplants From Donors With Hepatitis C May Be Safe: Study
Title: Heart Transplants From Donors With Hepatitis C May Be Safe: StudyCategory: Health NewsCreated: 1/13/2020 12:00:00 AMLast Editorial Review: 1/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 14, 2020 Category: Cardiology Source Type: news

Heart Transplants From Donors With Hepatitis C May Be Safe: Study
MONDAY, Jan. 13, 2020 -- One-year survival rates are similar for transplant patients who receive a heart from a donor with hepatitis C or one without the infectious virus, a new study finds. The researchers suggest that using hearts from donors with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 13, 2020 Category: General Medicine Source Type: news

Heart Transplants From Hep C Virus-Positive Donors Seem Safe
WEDNESDAY, Jan. 8, 2020 -- Adult heart transplants from hepatitis C virus-positive (HCV+) donors appear safe, with no increased risk for adverse effects on one-year survival, according to a study published online Jan. 8 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2020 Category: Pharmaceuticals Source Type: news

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage
(American Heart Association) One-year survival was 90% for adults with severe heart failure who received a heart transplant from a donor with hepatitis C, which was nearly identical to those who received a heart from donors who did not have hepatitis C (91%). Rates of organ rejection, stroke and kidney dialysis were similar between the two groups. More research is needed to assess longer-term results, however, increased use of hearts from donors with hepatitis C could help overcome the national shortage of donor organs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2020 Category: International Medicine & Public Health Source Type: news

Watchdog rejects use of genetic disorders drug in the NHS
NICE will not approve volanesorsen on the NHS Related items fromOnMedica NICE recommends Herceptin for gastric cancer H. pylori eradication linked to reduced risk of gastric cancer Use of DPP-4 inhibitors associated with increased risk of IBD Aspirin could also treat cancer, research suggests Antivirals cut liver cancer risk after hepatitis C (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 6, 2020 Category: UK Health Source Type: news

Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment
TUESDAY, Dec. 31, 2019 -- Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection, according to an article published online Dec. 17... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 31, 2019 Category: Pharmaceuticals Source Type: news

Updated Guidance for Hepatitis C Virus Treatment in Primary Care Updated Guidance for Hepatitis C Virus Treatment in Primary Care
Eradication of hepatitis C won't happen without the help of the primary care provider workforce.Medscape Family Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 24, 2019 Category: Infectious Diseases Tags: Gastroenterology Commentary Source Type: news

Hepatitis C-positive donors a viable option to expand heart donor pool
(Vanderbilt University Medical Center) Patients who were transplanted with hearts from hepatitis C-positive donors had comparable outcomes after one year to patients who received hearts from donors that didn't have the disease, according to a Vanderbilt University Medical Center study published in JAMA Cardiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2019 Category: International Medicine & Public Health Source Type: news

Heart transplants from donors positive for hepatitis C
(JAMA Network) Researchers at Vanderbilt University Medical Center in Nashville, Tenn., report in this case series on 80 patients who had heart transplants using hearts from donors positive for hepatitis C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 18, 2019 Category: Infectious Diseases Source Type: news

CDC Proposes Expanding its HCV Testing Recommendations
The CDC intends to expand its current recommendations for hepatitis C virus screening and is seeking public comment on the proposed changes, which would include one-time screening for adults 18 and older. (Source: AAFP News)
Source: AAFP News - December 17, 2019 Category: Primary Care Source Type: news

Dental patients advised to get tested for HIV, hepatitis
Some patients treated by a Tennessee dentist have been advised to get tested for HIV, hepatitis B and hepatitis C (Source: ABC News: Health)
Source: ABC News: Health - December 17, 2019 Category: Consumer Health News Tags: Health Source Type: news

Victory: Novartis withdraws an abusive patent for an over-priced cancer medication
On 3 July 2019, Doctors of the World and Public Eye, represented by Lionel Vial, filed a patent opposition at the European Patent Office against a patent covering Kymriah®. Kymriah® is a gene cancer therapy from Novartis, for which the French Social Security is billed €320,000 per patient. The aim was to denounce an abusive patent that aimed to strengthen a monopoly, allowing an exorbitant price to be imposed. At the end of November 2019, Novartis announced that it was withdrawing this patent and asked for it to be revoked. Novartis withdraws one of the patent covering Kymriah®, a victory achieved by&nbs...
Source: Doctors of the World News - December 16, 2019 Category: International Medicine & Public Health Authors: Martina Villa Tags: Uncategorised Source Type: news

Medical News Today: What to know about false positives in hepatitis C testing
Blood tests can usually show whether a person has hepatitis C. However, these tests can give false-positive readings. Here, learn why this can happen. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 12, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Prevention Benefits of a Treat-all Hepatitis C Strategy Prevention Benefits of a Treat-all Hepatitis C Strategy
This study modeled the prevention impact achieved from initiating a treat-all policy for HCV compared with treating different subgroups at country, regional and global levels.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Improvements needed for hepatitis C testing in youth
(Boston Medical Center) A new study led by Boston Medical Center uncovered a need to improve testing rates for Hepatitis C Virus (HCV) in young people, specifically those with documented substance use history. In the national data sample, under 30 percent of young patients who reported using opioids, methamphetamine, and/or cocaine were tested for HCV. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 10, 2019 Category: Infectious Diseases Source Type: news

Medical News Today: What is the prognosis for hepatitis C?
Hepatitis C (HCV) is a viral infection. Prognosis tends to depend on how soon a person receives a diagnosis and whether or not complications develop. Learn more about life expectancy with HCV here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

HCV Screening of Baby Boomers Continues to Lag in U.S. Safety-Net Clinics HCV Screening of Baby Boomers Continues to Lag in U.S. Safety-Net Clinics
Even with help, safety-net primary care clinics serving low-income and uninsured populations in the U.S. often fall short in screening baby boomers for hepatitis C virus (HCV), as recommended by the U.S. Preventive Services Task Force, according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Outcomes of Hep C Screening Intervention Examined
MONDAY, Dec. 2, 2019 -- A multicomponent intervention can improve hepatitis C virus (HCV) screening, although there is considerable variation by practice, according to a study published online Dec. 3 in the Annals of Internal Medicine. Barbara J.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2019 Category: Pharmaceuticals Source Type: news

Improved Survival Seen in Hepatoma Patients After HCV Cure Improved Survival Seen in Hepatoma Patients After HCV Cure
Cure of hepatitis C virus (HCV) infection with direct-acting antivirals is associated with increased survival in patients with HCV-related hepatocellular carcinoma (HCC), researchers report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 29, 2019 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

---
More than one thousand patients at Goshen Hospital in Indiana may have been exposed to HIV, hepatitis C and hepatitis B after an error in the sanitizing procedure for surgical equipment, according to a press release from Goshen Health. (Source: CNN.com - Health)
Source: CNN.com - Health - November 26, 2019 Category: Consumer Health News Source Type: news

More than 1,000 patients may have been exposed to HIV and other viruses after error in sanitizing procedure
More than a thousand surgical patients at Goshen Hospital in Indiana may have been exposed to HIV, hepatitis C and hepatitis B after an error in the sanitizing procedure for surgical equipment, according to a press release from Goshen Health. (Source: CNN.com - Health)
Source: CNN.com - Health - November 25, 2019 Category: Consumer Health News Source Type: news

Malaria discovery could lead to better HIV and lupus treatments
(Walter and Eliza Hall Institute) A discovery about how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus, say Melbourne researchers. The research team showed, in laboratory models, that strong inflammatory signals caused by malaria infection activate molecules that trigger the production of highly potent antibodies to fight the disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 19, 2019 Category: Biology Source Type: news

Treatment Response Rates High for Seniors With Hep C Infection
FRIDAY, Nov. 15, 2019 -- For patients with chronic hepatitis C infection, sustained viral response (SVR) rates are similar for those aged 65 years and older and those younger than 65, according to a study published online Oct. 24 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2019 Category: Pharmaceuticals Source Type: news

NHS scheme will give drug addicts up to £25 of GREGGS vouchers if they get tested for hepatitis C
The scheme will run in Newcastle and offer an incentive for needle users, who are at high risk of contracting the infectious virus from dirty syringes, to get a blood test at their local pharmacy. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2019 Category: Consumer Health News Source Type: news

HCV-Infected Donor Kidney Transplant as Standard Practice HCV-Infected Donor Kidney Transplant as Standard Practice
Should hepatitis C-infected kidneys be transplanted into uninfected recipients as standard practice? This editorial explores the issues.American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2019 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

Organs from patients with hepatitis C could be SAFE
Canadian researchers found giving uninfected recipients a combination of antiviral and cholesterol-lowering drugs prevented them from contracting the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - November 11, 2019 Category: Consumer Health News Source Type: news

For older adults, new hepatitis C treatments are safe and effective
(American Geriatrics Society) Thankfully, newer treatments known as interferon-free direct-acting antivirals offer a promising approach to addressing hepatitis C. These medications offer cure rates of more than 90 percent in clinical trials and in real life, but they haven't been studied extensively for older adults. A team of researchers studied this issue and published their findings in the Journal of the American Geriatrics Society. The researchers examined how well people older than 65 tolerated interferon-free direct-acting antivirals compared with younger patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 8, 2019 Category: Infectious Diseases Source Type: news

Prevalence of hepatitis C rates in Ohio may indicate highest areas of opioid misuse
(Ohio University) The Ohio Alliance for Innovation in Population Health (The Alliance) studied hepatitis C rates within the state and discovered consistently high rates in the southern Appalachia region over a five-year period. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 7, 2019 Category: Infectious Diseases Source Type: news

Menopause Occurs at Median Age of 48 in Canadian Women With HIV
WEDNESDAY, Nov. 6, 2019 -- Canadian women with HIV have a median age of menopause of 48 years, with lower education and hepatitis C coinfection independently associated with menopause at
Source: Drugs.com - Pharma News - November 6, 2019 Category: Pharmaceuticals Source Type: news

Liver Steatosis Predicts Poor Outcomes in Chronic HCV Liver Steatosis Predicts Poor Outcomes in Chronic HCV
A new study finds that the presence of liver steatosis may be a risk factor for all-cause mortality and hepatocellular carcinoma among chronic hepatitis C patients.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Patient-reported Outcomes in Chronic HCV vs. HBV Patient-reported Outcomes in Chronic HCV vs. HBV
This study compared quality of life scores in patients with chronic hepatitis C and hepatitis B, both before treatment initiation and at the time of full HBV suppression or HCV eradication.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 30, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Proficiency Testing of Viral Marker Screening in African Blood Centers - Seven African Countries, 2017
Following substantial investments in national blood transfusion service laboratories, in 2017 investigators tested proficiency at 84 blood center laboratories in seven African countries. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 24, 2019 Category: American Health Tags: Blood Safety Blood supply safety Global HIV/AIDS Hepatitis B Screening Hepatitis C MMWR Morbidity & Mortality Weekly Report South Africa Source Type: news

Efficacy and Safety of DAAs for Hepatitis C in the Elderly Efficacy and Safety of DAAs for Hepatitis C in the Elderly
This review assessed and compared the efficacy and safety of DAA therapy among the elderly and younger patients with chronic HCV infection. Are results comparable?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication - Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease
FDA has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic Hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or liver failure. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

IHS Awards $2.4 Million to Tribal Epidemiology Centers for Diagnosis, Treatment and Response to HIV, Hepatitis C and STIs
The Indian Health Service (IHS) has awarded $2.4 million to nine Tribal Epidemiology Centers to support the reduction of HIV, hepatitis C, and sexually transmitted infections in American Indian and Alaska Native communities. The Tribal Epidemiology Centers plan to implement a national strategy to diagnose, treat, prevent, and respond to HIV, with the goal of ending the epidemic by 2030. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - October 7, 2019 Category: Rural Health Source Type: news

Causes of hospital admission and mortality among 6683 people who use heroin: a cohort study comparing relative and absolute risks - Lewer D, Tweed EJ, Aldridge RW, Morley KI.
BACKGROUND: Mortality in high-risk groups such as people who use illicit drugs is often expressed in relative terms such as standardised ratios. These measures are highest for diseases that are rare in the general population, such as hepatitis C, and may u... (Source: SafetyLit)
Source: SafetyLit - October 5, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Hepatitis C Virus Infection Rates Up for Women Giving Birth
FRIDAY, Oct. 4, 2019 -- Among women giving birth, the rates of hepatitis C virus (HCV) infection increased more than 400 percent from 2000 to 2015, with rates much higher among those with opioid use disorder, according to research published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2019 Category: Pharmaceuticals Source Type: news